CVI IAI Online 2003
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00355-07v1
15/3/544    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Mizusawa, M.
Right arrow Articles by Hattori, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizusawa, M.
Right arrow Articles by Hattori, T.
Clinical and Vaccine Immunology, March 2008, p. 544-548, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00355-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Increased Synthesis of Anti-Tuberculous Glycolipid Immunoglobulin G (IgG) and IgA with Cavity Formation in Patients with Pulmonary Tuberculosis{triangledown}

Masako Mizusawa,1 Mizuoho Kawamura,2 Mikio Takamori,3 Tetsuya Kashiyama,3 Akira Fujita,3 Motoki Usuzawa,1 Hiroki Saitoh,1 Yugo Ashino,1 Ikuya Yano,4 and Toshio Hattori1*

Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8574,1 Fuji Research Laboratories, Kyowa Medex, Co., Ltd., Shizuoka 411-0932,2 Department of Respiratory Diseases, Tokyo Metropolitan Fuchu Hospital, Fuchu, Tokyo 183-8524,3 Japan BCG Central Laboratory, Kiyose, Tokyo 204-0022, Japan4

Received 23 August 2007/ Returned for modification 24 September 2007/ Accepted 19 December 2007

Tuberculous glycolipid (TBGL) antigen is a cell wall component of Mycobacterium tuberculosis and has been used for the serodiagnosis of tuberculosis. We investigated correlations between the levels of anti-TBGL antibodies and a variety of laboratory markers that are potentially influenced by tuberculous infection. Comparisons between patients with cavitary lesions and those without cavitary lesions were also made in order to determine the mechanism underlying the immune response to TBGL. Blood samples were obtained from 91 patients with both clinically and microbiologically confirmed active pulmonary tuberculosis (60 male and 31 female; mean age, 59 ± 22 years old). Fifty-nine patients had cavitary lesions on chest X-rays. Positive correlations were found between anti-TBGL immunoglobulin G (IgG) and C-reactive protein (CRP) (r = 0.361; P < 0.001), between anti-TBGL IgA and soluble CD40 ligand (sCD40L) (r = 0.404; P < 0.005), between anti-TBGL IgG and anti-TBGL IgA (r = 0.551; P < 0.0000005), and between anti-TBGL IgM and serum IgM (r = 0.603; P < 0.00000005). The patients with cavitary lesions showed significantly higher levels of anti-TBGL IgG (P < 0.005), anti-TBGL IgA (P < 0.05), white blood cells (P < 0.01), neutrophils (P < 0.005), basophils (P < 0.0005), natural killer cells (P < 0.05), CRP (P < 0.0005), KL-6 (sialylated carbohydrate antigen KL-6) (P < 0.0005), IgA (P < 0.05), and sCD40L (P < 0.01). The observed positive correlations between the anti-TBGL antibody levels and inflammatory markers indicate the involvement of inflammatory cytokines and NKT cells in the immunopathogenesis of pulmonary tuberculosis.


* Corresponding author. Mailing address: Division of Emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, Japan 980-8574. Phone: 81-227178220. Fax: 81-227178221. E-mail: hattori.t{at}rid.med.tohoku.ac.jp

{triangledown} Published ahead of print on 9 January 2008.

Present address: Jichi Medical University Hospital, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi 329-0498, Japan.


Clinical and Vaccine Immunology, March 2008, p. 544-548, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00355-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.